Morgan Cheatham: Excited to join the NIH for additional training in medical genetics and experimental pharmacology
Morgan Cheatham shared a post by NIH Clinical Center’s Office of Clinical Research Training and Medical Education (NIH CC MedEd), adding:
“Excited to join the National Institutes of Health (NIH) for additional training in medical genetics and experimental pharmacology. i’ll be in the DMV area through the fall – DMs are open!”
Quoting NIH CC MedEd‘s post:
“Welcome Morgan Cheatham! Morgan is coming from Warren Alpert Medical Schooland rotating with Medical Genetics with the NIH Clinical Electives Program.”
Source: Morgan Cheatham/X and NIH CC MedEd/X
Morgan Cheatham is the Vice President at Bessemer Venture Partners, where he focuses on investments in healthcare and life sciences. He is also a member of the editorial team at NEJM AI and a co-founder of Decoding Bio. Additionally, Cheatham serves as a Board Member for the Coalition for Health AI and FOLX Health. He also joined the National Human Genome Research Institute (NHGRI) at NIH for training in medical genetics and experimental pharmacology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023